We have won more than $40 billion in jury verdicts and settlements and have been in business for almost 70 years.
Coumadin — See Warfarin
Rivaroxaban (marketed as Xarelto) is an oral anticoagulant and active direct factor Xa inhibitor. The U.S. Food and Drug Administration (FDA) has approved the use of the drug to help prevent deep vein thrombosis in adults undergoing hip and knee replacement surgery, and to help prevent strokes in patients with non-valvular atrial fibrillation. For detailed information on this drug, please visit http://en.wikipedia.org/wiki/Rivaroxaban
Warfarin(also known by the brand names Coumadin, Jantoven, Marevan, Uniwarfin) is an anticoagulant initially introduced in 1948 as a pesticide against rats and mice. In the early 1950s, it was found to be effective and relatively safe for preventing thrombosis and thromboembolism in many disorders. It was approved for use as a medication in 1954, and has remained popular ever since. It is the most widely prescribed oral anticoagulant drug in North America. Warfarin decreases blood coagulation by inhibiting vitamin K. For detailed information on this drug, please visit http://en.wikipedia.org/wiki/Warfarin
Xarelto — See Rivoroxaban
By clicking the "I agree" and "Submit for Free Evaluation" buttons, I agree to the POLICIES AND DISCLAIMERS, including arbitration provision therein, and consent to receive marketing emails, calls and/or texts, including those made using an automated system and/or artificial/prerecorded voice messages, from or on behalf of Levin Papantonio Rafferty regarding their services in response to my inquiry at the telephone number(s) provided above, even if currently listed on any state, federal or corporate Do Not Call registry. I understand my consent to receive automated marketing calls/texts is not required as a condition of purchasing any services. However, if I do not consent, then I must call the law firm directly at 800-277-1193 in order to obtain services. I can revoke my consent at any time.